Benefit-risk assessment of incretin and other anti-diabetic agents in type 2 diabetes using a stochastic multicriteria acceptability analysis model

Detalles Bibliográficos
Autores principales: Chai, Sanbao, Yu, Shuqing, Liu, Fengqi, Liu, Zuoxiang, Yang, Qingqing, Sun, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106192/
https://www.ncbi.nlm.nih.gov/pubmed/36723862
http://dx.doi.org/10.1097/CM9.0000000000002520

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10106192/
https://www.ncbi.nlm.nih.gov/pubmed/36723862
http://dx.doi.org/10.1097/CM9.0000000000002520

Ejemplares similares